1. A. On receipt of specific instructions from the authorized prescriber regarding a specific patient, the pharmacist may execute the authorized prescriber’s specific instructions even if the instructions deviate from the protocol.
2. B. The protocol may not prohibit the pharmacist from providing other pharmaceutical services that are within the pharmacist's scope of practice.

3. C. Documentation of activities performed under a protocol or the authorized prescriber’s specific instructions shall be maintained in such a manner that it is accessible to the:

   1. (1) Authorized prescriber; and
   2. (2) Pharmacist.
4. D. Documentation may be maintained in written or electronic form.
5. E. Oral communications between the authorized prescriber and pharmacist shall be summarized in the documentation maintained by the pharmacist and forwarded to the authorized prescriber.

6. F. Unless an alternative time period is stated in the prescriber-pharmacist agreement, the pharmacist shall inform the authorized prescriber within 48 hours if the pharmacist:

   1. (1) Modifies the dose or agent under the therapy management contract;
   2. (2) Detects an abnormal result from an assessment activity; or
   3. (3) Initiates drug therapy under a written, disease-state specific protocol, for protocols by a licensed physician and pharmacist.

Authority: Health Occupations Article, §§12-6A-01 — 12-6A-10, Annotated Code of Maryland

Effective date: December 11, 2003 (30:24 Md. R. 1742)

Chapter revised effective April 15, 2013 (40:7 Md. R. 611)

Regulation .01B amended effective March 28, 2016 (43:6 Md. R. 409)

Regulation .02 amended effective March 28, 2016 (43:6 Md. R. 409)

Regulation .03 amended effective March 28, 2016 (43:6 Md. R. 409)

Regulation .04 amended effective March 28, 2016 (43:6 Md. R. 409)

Regulation .05 amended effective March 28, 2016 (43:6 Md. R. 409)

Regulation .06 amended effective March 28, 2016 (43:6 Md. R. 409)

Regulation .07 amended effective March 28, 2016 (43:6 Md. R. 409)